| Michele Jorgensen, CCC-SLP | |
|
1310 S Union Ave Ste A100, Tacoma, WA 98405-1907 | |
| (253) 383-2423 | |
| Not Available |
| Full Name | Michele Jorgensen |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1310 S Union Ave Ste A100, Tacoma, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972677490 | NPI | - | NPPES |
| 8344954 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00002660 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michele Jorgensen, CCC-SLP 214 Summit Ave, Fircrest, WA 98466-7422 Ph: () - | Michele Jorgensen, CCC-SLP 1310 S Union Ave Ste A100, Tacoma, WA 98405-1907 Ph: (253) 383-2423 |
News Archive
Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp., providing Sorrento with a comprehensive technology platform to create a new generation of homogenous antibody drug conjugates with site-specific toxin conjugation and consistent drug-antibody ratios. With the close of the deal, Sorrento has issued an aggregate of 1,331,978 shares of its common stock to the Concortis shareholders. Based on the closing share price on December 18, 2013, the transaction is valued at $11.3 million.
The Associated Press: "Americans increasingly are treated to death, spending more time in hospitals in their final days, trying last-ditch treatments that often buy only weeks of time, and racking up bills that have made medical care a leading cause of bankruptcies. More than 80 percent of people who die in the United States have a long, progressive illness such as cancer, heart failure or Alzheimer's disease."
Inflammatory arthritis is the name for a group of diseases that cause joint pain and swelling. This happens because the body's immune system attacks its own tissues and causes inflammation.
Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ADVATE [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method] for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A.
› Verified 5 days ago
Andrea Lynn Rottier, LL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4301 S Pine St, Ste 219, Tacoma, WA 98409 Phone: 253-476-6550 | |
Janet Kobayashi-hobson, CCC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Christine L Camp, PH.D., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2106 E 44th St, Tacoma, WA 98404 Phone: 253-571-2908 | |
Ann S Lewis, B.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1202 S 76th St, Tacoma, WA 98408 Phone: 253-571-4579 | |
Angela Curtis, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-7919 | |
Porsche Maneice, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 242 St Helens Ave, Tacoma, WA 98402 Phone: 253-627-3833 | |
Peggy Lesniak, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1310 S Union Ave Ste A100, Tacoma, WA 98405 Phone: 253-383-2423 |